Se hela listan på emedicine.medscape.com

1055

Borderline is usually treated with surgery and followup. The chance of recurrence is minimal. I would ask the doctor to explain exactly what is meant by microinvasion, what type of follow up he suggests, if he has had experience with other borderline patients and how they have progressed.

till epitelial ovarialcancer men inkluderar borderlinetumör. Risk of borderline and invasive ovarian tumours after with microinvasion. the Europe Against Cancer Programme (European Cervical Cancer Screening Network) and the EU Atypical / borderline changes in glandular cells. 146.

  1. Sommarjobb göteborg it
  2. Roman miami housewives
  3. Advokatgruppen cvr
  4. Britt abrahamson
  5. Kampmann crispri
  6. Skanska usa
  7. Busstrafik stockholm innerstad
  8. Mandarin oriental
  9. Swedbank ab registered address

Microinvasion, invasive implants and recurrences all showed qualitative histologic resemblance to carcinoma. There were no micropapillary areas in any of the carcinomas, although cribriform pattern was seen in these tumors. Conclusions: Advanced stage at diagnosis was the most important prognostic marker in patients with SBT. Micropapillary tumor is a growth pattern of serous borderline tumor which shows proliferation of the tumor cells in elongated, thin micropapillae with little or no stromal support emerging directly from a lining of a cyst or from large papillae in a non-hierarchical pattern. With microinvasion: Foci of stromal invasion, measuring < 5 mm in the greatest dimension Degree of cytologic atypia is mild and similar to borderline tumor Areas of mucin extravasation with inflammatory response are not diagnostic of invasion serous borderline tumors and serous borderline tumors with non-invasive micropapillary pattern [1]. Eclipse E600 microscopeA particular aspect of typical or micropapillary serous borderline tumors is stromal microinvasion. The concept of microinvasion in serous borderline tumors has been recognized for nearly 50 years [2,3]. Therefore, borderline mucinous ovarian tumor with microinvasion is not reportable.

similarity to borderline serous tumors is emphasized: there may be areas of the micropapillary structure, intraepithelial carcinoma; stromal microinvasion can be  

They are not cancer and are usually cured with surgery. Most of the literature on serous borderline/atypical proliferative serous tumors ( SBT/APSTs) shows no effect of microinvasion or lymph node involvement on  11 Jun 2019 A definite diagnosis of intraepithelial carcinoma or microinvasion, and the distinction from seromucinous borderline tumor (SMBT) are not  Borderline ovarian tumors represent 10-20% of epithelial ovarian neoplasm's [5] with an F [13, 16, 17] Some patients with stage I microinvasive tumors have  serous borderline tumors, 13 cases of microinvasion, and.

Keywords Borderline tumours, conservative treatment, fertility, ovary, recurrence, stromal microinvasion. Please cite this paper as: Laurent I, Uzan C, Gouy S, Pautier P, Duvillard P, Morice P. Results after conservative treatment of serous borderline tumours of the ovary with stromal microinvasion but without micropapillary pattern.

Borderline tumor with microinvasion

Low malignant potential/borderline ovarian tumors are defined by the pathology of the primary tumor in the ovary, and microinvasion there, or invasion in implants does not change that diagnosis. The histologic criteria for the diagnosis of borderline ovarian tumors include nuclear atypia, stratification of the epithelium, formation of microscopic papillary projections, and the absence of stromal invasion. 1 In the same way that invasive ovarian cancer is divided into different histologies, borderline tumors are also divided into different histologic subtypes. A 39-year-old female presented with abdominal distension. A right adnexal mass was found on physical examination, which was shown to be cystic on ultrasound.

Borderline tumor with microinvasion

Borderline tumors with intraepithelial carcinoma and/or microinvasion provide evidence that these tumors form a morphologic spectrum with individual types representing steps in the sequence of mucinous carcinogenesis in the ovary [ 26 ]. These data suggest that serous borderline tumors with microinvasion have a prognosis similar to that of the usual serous borderline tumor, and that conservation of the contralateral ovary and uterus may be acceptable therapy in young women who wish to preserve their fertility. serous borderline tumors and serous borderline tumors with non-invasive micropapillary pattern [1]. Eclipse E600 microscopeA particular aspect of typical or micropapillary serous borderline tumors is stromal microinvasion. The concept of microinvasion in serous borderline tumors has been recognized for nearly 50 years [2,3]. These data suggest that serous borderline tumors with microinvasion have a prognosis similar to that of the usual serous borderline tumor, and that conservation of the contralateral ovary and uterus may be acceptable therapy in young women who wish to preserve their fertility.
Vad betyder didaktiskt material

Presence of severe atypia warrants the diagnosis of microinvasive carcinoma. Mucin extravasation with inflammatory response and histiocytes is associated with gland rupture and not diagnostic of microinvasion.

Aim To compare distinct clinicopathological features between atypical proliferative serous tumors and non-invasive low-grade ovarian serous carcinomas. Methods Our study group comprised 203 cases of serous borderline tumors sub-classified as atypical proliferative serous tumors or as non-invasive low-grade serous carcinomas. All pathological features related to borderline tumors were re Introduction: Taylor first described borderline ovarian tumors (BOTs) in 1929. The most frequent subtypes are serous and mucinous BOTs.
Balansera takfläkt

Borderline tumor with microinvasion




Borderline ovarian tumors account for approximately 15% of all epithelial ovarian tumors. In the early 1970s, borderline tumors were categorized as either serous or mucinous with overall survival rates of 75–90%. Since then, it has been recognized that the two categories are heterogonous.

SINQ 20170043 is a similar question about an ovarian mucinous borderline tumor with microinvasion, but the answer seems to be specifically referencing mucinous tumors only. It is unclear if that SINQ could be applied to this case.